300 related articles for article (PubMed ID: 7518280)
21. A proposed clinical test for monitoring fluoropyrimidine therapy: detection and stability of thymidylate synthase ternary complexes.
Brody JR; Gallmeier E; Yoshimura K; Hucl T; Kulesza P; Canto MI; Hruban RH; Schulick RD; Kern SE
Cancer Biol Ther; 2006 Aug; 5(8):923-7. PubMed ID: 16855390
[TBL] [Abstract][Full Text] [Related]
22. Leucovorin enhancement of the effects of the fluoropyrimidines on thymidylate synthase.
Morgan RG
Cancer; 1989 Mar; 63(6 Suppl):1008-12. PubMed ID: 2521810
[TBL] [Abstract][Full Text] [Related]
23. Thymidylate synthase inhibitors.
Ackland SP; Clarke SJ; Beale P; Peters GJ
Cancer Chemother Biol Response Modif; 2002; 20():1-36. PubMed ID: 12703198
[No Abstract] [Full Text] [Related]
24. Targeting thymidylate synthase in colorectal cancer: critical re-evaluation and emerging therapeutic role of raltitrexed.
Avallone A; Di Gennaro E; Silvestro L; Iaffaioli VR; Budillon A
Expert Opin Drug Saf; 2014 Jan; 13(1):113-29. PubMed ID: 24093908
[TBL] [Abstract][Full Text] [Related]
25. Drug resistance in colon cancer.
Gorlick R; Bertino JR
Semin Oncol; 1999 Dec; 26(6):606-11. PubMed ID: 10606253
[TBL] [Abstract][Full Text] [Related]
26. An update on thymidylate synthase inhibitors.
Hughes A; Calvert H
Ann Oncol; 1999 Oct; 10(10):1137-9. PubMed ID: 10586328
[No Abstract] [Full Text] [Related]
27. Tumor cell responses to inhibition of thymidylate synthase.
Moran RG; Keyomarsi K; Patel R
Adv Exp Med Biol; 1988; 244():71-83. PubMed ID: 2977717
[TBL] [Abstract][Full Text] [Related]
28. Antifolate inhibitors of thymidylate synthase as anticancer drugs.
Jarmuła A
Mini Rev Med Chem; 2010 Nov; 10(13):1211-22. PubMed ID: 20854257
[TBL] [Abstract][Full Text] [Related]
29. Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil. Is it time to move forward?
Showalter SL; Showalter TN; Witkiewicz A; Havens R; Kennedy EP; Hucl T; Kern SE; Yeo CJ; Brody JR
Cancer Biol Ther; 2008 Jul; 7(7):986-94. PubMed ID: 18443433
[TBL] [Abstract][Full Text] [Related]
30. MTA, a novel multitargeted antifolate, from preclinical to phase I and beyond: summary and conclusions.
Calvert H
Semin Oncol; 1999 Apr; 26(2 Suppl 6):105-8. PubMed ID: 10598564
[No Abstract] [Full Text] [Related]
31. Pemetrexed: a multitargeted antifolate (ALIMTA, LY-231514).
Jones RJ; Twelves CJ
Expert Rev Anticancer Ther; 2002 Feb; 2(1):13-22. PubMed ID: 12113062
[TBL] [Abstract][Full Text] [Related]
32. Folate depletion increases sensitivity of solid tumor cell lines to 5-fluorouracil and antifolates.
Backus HH; Pinedo HM; Wouters D; Padrón JM; Molders N; van Der Wilt CL; van Groeningen CJ; Jansen G; Peters GJ
Int J Cancer; 2000 Sep; 87(6):771-8. PubMed ID: 10956384
[TBL] [Abstract][Full Text] [Related]
33. Pemetrexed, an novel multitargeted antifolate: current development and future directions. Proceedings of a meeting. August 17-19, 2000. Colorado Springs, Colorado, USA.
Semin Oncol; 2002 Apr; 29(2 Suppl 5):1-61; quiz 62-9. PubMed ID: 12023785
[No Abstract] [Full Text] [Related]
34. Clinical trials referral resource. Clinical trials with tomudex.
Sorensen JM; Cheson BD; Phillips PH
Oncology (Williston Park); 1996 Jul; 10(7):1041-2. PubMed ID: 8837120
[No Abstract] [Full Text] [Related]
35. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.
van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ
Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838
[TBL] [Abstract][Full Text] [Related]
36. Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapy.
Findlay MP; Cunningham D; Morgan G; Clinton S; Hardcastle A; Aherne GW
Br J Cancer; 1997; 75(6):903-9. PubMed ID: 9062414
[TBL] [Abstract][Full Text] [Related]
37. Thymidylate synthase structure, function and implication in drug discovery.
Costi MP; Ferrari S; Venturelli A; Calò S; Tondi D; Barlocco D
Curr Med Chem; 2005; 12(19):2241-58. PubMed ID: 16178783
[TBL] [Abstract][Full Text] [Related]
38. MTA, A Novel Multitargeted Antifolate: from preclinical to phase I and beyond. Proceedings of a meeting. Ixtapa, Mexico, March 13-15, 1998.
Semin Oncol; 1999 Apr; 26(2 Suppl 6):1-110. PubMed ID: 10610578
[No Abstract] [Full Text] [Related]
39. Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism.
Peters GJ; Backus HH; Freemantle S; van Triest B; Codacci-Pisanelli G; van der Wilt CL; Smid K; Lunec J; Calvert AH; Marsh S; McLeod HL; Bloemena E; Meijer S; Jansen G; van Groeningen CJ; Pinedo HM
Biochim Biophys Acta; 2002 Jul; 1587(2-3):194-205. PubMed ID: 12084461
[TBL] [Abstract][Full Text] [Related]
40. ZD1694 (Tomudex): a new thymidylate synthase inhibitor with activity in colorectal cancer.
Jackman AL; Farrugia DC; Gibson W; Kimbell R; Harrap KR; Stephens TC; Azab M; Boyle FT
Eur J Cancer; 1995; 31A(7-8):1277-82. PubMed ID: 7577036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
